Journal of Vascular and Interventional Radiology
Volume 20, Issue 1 , Pages 3-8, January 2009

Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors

  • Debra A. Gervais, MD

      Affiliations

    • Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, White 270, 55 Fruit St, Boston, MA 02114
    • Corresponding Author InformationAddress correspondence to D.A.G.
    • ,
  • S. Nahum Goldberg, MD

      Affiliations

    • Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
    • ,
  • Daniel B. Brown, MD

      Affiliations

    • Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
    • ,
  • Michael C. Soulen, MD

      Affiliations

    • Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Steven F. Millward, MD

      Affiliations

    • Department of Radiology, University of Western Ontario, London, Canada, and Peterborough Regional Health Center, Peterborough, Ontario, Canada
    • ,
  • Dheeraj K. Rajan, MD

      Affiliations

    • Division of Vascular & Interventional Radiology, Department of Medical Imaging, University of Toronto, University Health Network, Toronto, Ontario, Canada

Received 30 May 2008; received in revised form 5 September 2008; accepted 5 September 2008. published online 23 October 2008.

Focal tumor ablation—whether applied percutanously, laparoscopically, or by means of open surgery—is an effective therapy for selected liver tumors. The choice of liver ablation as well as the choice between percutaneous and surgical approaches is dependent on tumor factors, patient factors, and other viable treatment options. Currently, the largest cumulative reported experience is with radiofrequency (RF) ablation of hepatocellular carcinoma and colorectal metastases. This document is a position statement of the Interventional Oncology Task Force and the Standards Division of the Society of Interventional Radiology regarding the use of percutaneous RF ablation for the treatment of liver tumors.

Abbreviations: HCC, hepatocellular carcinoma, OLT, orthotopic liver transplantation, RF, radiofrequency

 

 D.A.G. is a paid consultant for Covidien. S.N.G. is a paid consultant for AngioDynamics.

PII: S1051-0443(08)00809-9

doi:10.1016/j.jvir.2008.09.007

Journal of Vascular and Interventional Radiology
Volume 20, Issue 1 , Pages 3-8, January 2009

Article Tools